May 11, 2017 / 10:37 AM / in 3 months

BRIEF-Knight therapeutics Q1 EPS $0.04

1 Min Read

May 11 (Reuters) - Knight Therapeutics Inc :

* Knight Therapeutics Inc qtrly revenues of $1.8 million, an increase of $682,000 over same period last year

* Knight reports first quarter 2017 results

* Qtrly diluted earnings per share $0.04

* Received full repayment of balance of secured loans to Apicore Inc. and Pro Bono Bio Plc in the quarter Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below